Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

0
Player Avatar CarlosDK (< 20) Submitted: 1/23/2013 7:57:05 AM : Underperform Start Price: $3.99 ARRY Score: +23.44

TOS: TOP HS pattern

Featured Broker Partners


Advertisement